An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia (Q28362661)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia	scientific article

Statements

scholarly article

0 references

An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia (English)

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

coronary artery disease

1 reference

based on heuristic

inferred from title

author name string

P N Durrington

1

0 references

D Bhatnagar

2

0 references

M I Mackness

3

0 references

J Morgan

4

0 references

K Julier

5

0 references

M A Khan

6

0 references

M France

7

0 references

language of work or name

0 references

publication date

May 2001

0 references

0 references

85

0 references

544-8

0 references

5

0 references

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

7 April 2017

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

7 April 2017

Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

7 April 2017

Dietary marine fish oils and insulin action in type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

29 September 2017

Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

29 September 2017

Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

29 September 2017

Fish oil and glycemic control in diabetes. A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

2 June 2018

Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

2 June 2018

Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

2 June 2018

Effect of glyburide andω3 fatty acid dietary supplements on glucose and lipid metabolism in patients with non-insulin-dependent diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

2 June 2018

N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

27 November 2018

Effects of a small quantity of omega-3 fatty acids on cardiovascular risk factors in NIDDM. A randomized, prospective, double-blind, controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

27 November 2018

Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1729738

27 November 2018

Reduction of plasma lipids, lipoproteins, and apoproteins by dietary fish oils in patients with hypertriglyceridemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11303007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/11303007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hypotriglyceridemic effect of fish oil in adult-onset diabetes without adverse glucose control

1 reference

https://pubmed.ncbi.nlm.nih.gov/11303007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of pravastatin and omega-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11303007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum triglycerides and HDL cholesterol--major predictors of long-term survival after coronary surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/11303007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fish consumption, fish oil, lipids, and coronary heart disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/11303007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of Simvastatin and omega-3 fatty acids on plasma lipoproteins and lipid peroxidation in patients with combined hyperlipidaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11303007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipid-lowering drugs: who gets what?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11303007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/11303007

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HEART.85.5.544

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28362661&oldid=1978059859"